Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Schippinger

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
European Geriatric Medicine|December 15, 2018
Optimizing medical care for geriatric patients in Austria: defining a top five list of "Choosing Wisely" recommendations using the Delphi techniqueWalter Schippinger, Anna Glechner, Karl Horvath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapyMartin Filipits, Margaretha Rudas, Harald Heinzl, et al.
Ebiomedicine|October 2, 2015
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer PatientsDaniela Kandioler, Martina Mittlböck, Sonja Kappel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapyMargaretha Rudas, Martina Lehnert, Anh Huynh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapyPeter Dubsky, Paul Sevelda, Raimund Jakesz, et al.
The New England Journal of Medicine|February 14, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancerMichael Gnant, Brigitte Mlineritsch, Walter Schippinger, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
European Geriatric Medicine|December 15, 2018
Optimizing medical care for geriatric patients in Austria: defining a top five list of "Choosing Wisely" recommendations using the Delphi techniqueWalter Schippinger, Anna Glechner, Karl Horvath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapyMartin Filipits, Margaretha Rudas, Harald Heinzl, et al.
Ebiomedicine|October 2, 2015
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer PatientsDaniela Kandioler, Martina Mittlböck, Sonja Kappel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapyMargaretha Rudas, Martina Lehnert, Anh Huynh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapyPeter Dubsky, Paul Sevelda, Raimund Jakesz, et al.
The New England Journal of Medicine|February 14, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancerMichael Gnant, Brigitte Mlineritsch, Walter Schippinger, et al.
Pageof 4